CHIP and Residual Cardiovascular Event Tendency After Smoking Cessation (CHIP-RETENTION)

Shenyang Northern Hospital

Status

Completed

Conditions

Clonal Hematopoiesis of Indeterminate Potential

ACS

Smoking Cessation

Treatments

Genetic: clonal hematopoiesis of indeterminate potential

Study type

Observational

Funder types

Other

Identifiers

NCT04987268

CHIP RETENTION V1.0

Details and patient eligibility

About

In order to identify the association between clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular risks after smoking cessation, this study intends to recruit ACS patients undergoing complete revascularization and perform whole-exome sequencing for enrolled patients to identify the prevalence of CHIP mutations. After 1-year follow-up, the relationship of presence of CHIP mutations and the occurrence of MACCEs will be explored, irrespective of smoking cessation or not. CHIP may be a potential risk factor of poor prognosis of ACS.

Enrollment

1,029 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

1. In-patients with acute coronary syndrome to undergo PCI 2. Complete revascularization during the index hospitalization 3. Written informed consent

Exclusion criteria

1. Periprocedural complications (coronary artery dissection, perforation, myocardial infarction, stroke, death) 2. Planned coronary revascularization at discharge 3. Patients with severe chronic disease (uremia, liver cirrhosis, COPD (chronic obstructive pulmonary disease) 4. Abnormal blood counts caused by hematological diseases 5. Diagnosed malignancy